Immunotherapies in the German healthcare system Economic aspects of established antibodies and recently available therapies von Huppertz, Eduard

Volltext

Economic burden of vulvar and vaginal intraepithelial neoplasia: retrospective cost study at a German dysplasia centre von Hampl, Monika, Huppertz, Eduard, Schulz-Holstege, Olaf, Kok, Patrick, Schmitter, Sarah

Volltext

Immuntherapien im deutschen Gesundheitswesen: Ökonomische Aspekte etablierter Antikörper und neuerer Therapien von Huppertz, Eduard

Volltext

Immuntherapien im deutschen Gesundheitswesen von Huppertz, Eduard Dr

Volltext

Cost effectiveness of enoxaparin as prophylaxis against venous thromboembolic complications in acutely ill medical inpatients : Modelling study from the hospital perspective in Ger... von SCHÄDLICH, Peter K, KENTSCH, Michael, WEBER, Manfred, KÄMMERER, Wolfgang, GEORG BRECHT, Josef, NADIPELLI, Vijay, HUPPERTZ, Eduard

Volltext

Cost effectiveness of ramipril in patients at high risk for cardiovascular events: Economic evaluation of the HOPE (Heart Outcomes Prevention Evaluation) study for germany from the... von SCHÄDLICH, Peter K, BRECHT, Josef Georg, RANGOONWALA, Badrudin, HUPPERTZ, Eduard

Volltext

Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide in rheumatoid arthritis in Germany. I. Selected DMARDs and patient-related costs von SCHÄDLICH, Peter K, ZEIDLER, Henning, ZINK, Angela, GROMNICA-IHLE, Erika, SCHNEIDER, Matthias, STRAUB, Christoph, BRECHT, Josef G, HUPPERTZ, Eduard

Volltext

Economic evaluation of enoxaparin for anticoagulation in early cardioversion of persisting nonvalvular atrial fibrillation: a statutory health insurance perspective from Germany von Schädlich, Peter K, Schmidt-Lucke, Caroline, Huppertz, Eduard, Lehmacher, Walter, Nixdorff, Uwe, Stellbrink, Christoph, Brecht, Josef Georg

Volltext

Modelling cost effectiveness and cost utility of sequential DMARD therapy including leflunomide for rheumatoid arthritis in Germany. II. The contribution of leflunomide to efficien... von SCHÄDLICH, Peter K, ZEIDLER, Henning, ZINK, Angela, GROMNICA-IHLE, Erika, SCHNEIDER, Matthias, STRAUB, Christoph, BRECHT, Josef G, HUPPERTZ, Eduard

Volltext

Cost effectiveness of ramipril in patients with non-diabetic nephropathy and hypertension: economic evaluation of Ramipril Efficacy in Nephropathy (REIN) Study for Germany from the... von Schädlich, P K, Brecht, J G, Brunetti, M, Pagano, E, Rangoonwala, B, Huppertz, E

Volltext

Cost-effectiveness analysis of ramipril in heart failure after myocardial infarction. Economic evaluation of the Acute Infarction Ramipril Efficacy (AIRE) study for Germany from th... von Schädlich, P K, Huppertz, E, Brecht, J G

Volltext